NCT01078805View on ClinicalTrials.gov

Study of FORTEO Use in Subjects in the Community Setting

CompletedOBSERVATIONAL

Enrollment

4,167

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions

Osteoporosis

Interventions

DRUG

FORTEO

prescribed in accordance with usual clinical practice for up to 24 months

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lakewood

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT01078805 - Study of FORTEO Use in Subjects in the Community Setting | Biotech Hunter | Biotech Hunter